Concord Medical Services Stock Beta
| CCM Stock | USD 8.51 0.66 8.41% |
Fundamental analysis of Concord Medical allows traders to better anticipate movements in Concord Medical's stock price by examining its financial health and performance throughout various phases of its business cycle.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Concord Medical Services Company Beta Analysis
Concord Medical's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current Concord Medical Beta | -0.64 |
Most of Concord Medical's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Concord Medical Services is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
| Competition |
In accordance with the recently published financial statements, Concord Medical Services has a Beta of -0.638. This is 174.19% lower than that of the Health Care Providers & Services sector and significantly lower than that of the Health Care industry. The beta for all United States stocks is notably higher than that of the company.
Concord Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Concord Medical's direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Concord Medical could also be used in its relative valuation, which is a method of valuing Concord Medical by comparing valuation metrics of similar companies.Concord Medical is currently under evaluation in beta category among its peers.
As returns on the market increase, returns on owning Concord Medical are expected to decrease at a much lower rate. During the bear market, Concord Medical is likely to outperform the market.
Concord Fundamentals
| Return On Equity | -0.39 | ||||
| Return On Asset | -0.0521 | ||||
| Profit Margin | (0.80) % | ||||
| Operating Margin | (2.02) % | ||||
| Current Valuation | 8.5 B | ||||
| Shares Outstanding | 2.82 M | ||||
| Shares Owned By Insiders | 17.99 % | ||||
| Shares Owned By Institutions | 0.03 % | ||||
| Number Of Shares Shorted | 18.62 K | ||||
| Price To Earning | (3.90) X | ||||
| Price To Book | 3.00 X | ||||
| Price To Sales | 0.07 X | ||||
| Revenue | 383.96 M | ||||
| Gross Profit | (79.16 M) | ||||
| EBITDA | (411.03 M) | ||||
| Net Income | (308.24 M) | ||||
| Cash And Equivalents | 157.39 M | ||||
| Cash Per Share | 1.72 X | ||||
| Total Debt | 1.03 B | ||||
| Debt To Equity | 1.25 % | ||||
| Current Ratio | 0.71 X | ||||
| Book Value Per Share | (525.23) X | ||||
| Cash Flow From Operations | (397.75 M) | ||||
| Short Ratio | 0.76 X | ||||
| Earnings Per Share | (9.66) X | ||||
| Target Price | 1.2 | ||||
| Number Of Employees | 595 | ||||
| Beta | -0.64 | ||||
| Market Capitalization | 34.08 M | ||||
| Total Asset | 6.73 B | ||||
| Retained Earnings | (4.37 B) | ||||
| Working Capital | (1.14 B) | ||||
| Current Asset | 1.51 B | ||||
| Current Liabilities | 1.51 B | ||||
| Net Asset | 6.73 B |
About Concord Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Concord Medical Services's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Concord Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Concord Medical Services based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Concord Medical Piotroski F Score and Concord Medical Altman Z Score analysis. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Concord Medical. If investors know Concord will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Concord Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Concord Medical Services is measured differently than its book value, which is the value of Concord that is recorded on the company's balance sheet. Investors also form their own opinion of Concord Medical's value that differs from its market value or its book value, called intrinsic value, which is Concord Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Concord Medical's market value can be influenced by many factors that don't directly affect Concord Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Concord Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Concord Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Concord Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.